The global airway clearance systems market size is expected to reach USD 852.9 million by 2030, expanding at a CAGR of 5.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The airway or mucus clearance devices are majorly used for the treatment of various respiratory diseases. Rising adoption of clearance system to curb the surmounting prevalence of cystic fibrosis, Chronic Obstructive Pulmonary Disease (COPD), bronchiectasis is the primary market driver.
According to the U.S. Department of Health and Human Services, About 1 in every 2,500 to 3,500 Caucasian babies is diagnosed with cystic fibrosis in U.S. This ratio significantly lower among Asian and African Americans at 1 in 31,000 and 17,000 births, respectively. This factor is expected to contribute to the product demand over the forecast period.
Breakthroughs in airway clearance systems are anticipated to positively influence the market. For instance, as manufactured by Dymedso, a digitally controlled acoustic airway clearance device endorses bronchial drainage by inducing vibration in the thoracic walls. Leading to a less painful and more effective treatment. Groundbreaking technological advancements are rapidly transforming the airway clearance devices, creating new growth opportunities.
Key players operating in the airway clearance systems market are Hill-Rom Holdings, Inc.; Electromed Inc.; Aptalis Pharma U.S. Inc.; and Thayer Medical. These players account for a significant market share, owing to their broad product offerings. Microsoft, Great Ormond Street Hospital, and University College London have collaborated to develop Project Fizzyo, to make the cystic fibrosis treatment more enjoyable for the children. This project gamifies the treatment with the help of innovative technology.
Major market players are focusing on increasing their brand penetration and acceptance by collaborating with insurance companies. For instance, under Patient Assistance Program, Hill-Rom offers access to VitalCough System and Vest Airway Clearance System for reducing the financial burden from the eligible patients.
Request a free sample copy or view report summary: Airway Clearance Systems Market Report
Flutter mucus clearance device held the dominant market share in 2023 due to cost effectiveness, ease of use, and easy portability of the product
Cystic fibrosis segment held the largest market share in 2023 and is anticipated to witness significant CAGR over the forecast period due to growing patient population and available of patient care support
Home care settings held the dominant market share in 2023 mainly due to ease of therapy accessed from the comfort of home
Baxter; Electromed Inc.; Koninklijke Philips N.V.; Med Systems, Inc. And AbbVie Inc are some of the major market player
Grand View Research has segmented the global airway clearance systems market based on device, application, end use, and region:
Airway Clearance Systems Device Type Outlook (Revenue, USD Million, 2018 - 2030)
Positive Expiratory Pressure (PEP)
Flutter Mucus Clearance Device
High Frequency Chest Wall Oscillation (HFCWO)
Intrapulmonary Percussive Ventilation (IPV)
Others
Airway Clearance Systems Application Outlook (Revenue, USD Million, 2018 - 2030)
Cystic Fibrosis
Neuromuscular
Bronchiectasis
Others
Airway Clearance Systems End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals and Clinics
Home care settings
Ambulatory Surgical Centers
Others
Airway Clearance Systems Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Asia Pacific
China
Japan
India
South Korea
Australia
Latin America
Brazil
Middle East and Africa (MEA)
KSA
UAE
South Africa
List of Key Players in the Airway Clearance Systems Market
Baxter
Electromed, Inc
Koninklijke Philips N.V.
General Physiotherapy II LLC
AbbVie Inc
Med Systems, Inc.
Smiths Group plc
VYAIRE
PARI GmbH
Dymedso
"The quality of research they have done for us has been excellent..."